“This patent is a breakthrough for Nutri Pharma’s line of products in the European markets ”, says Michael Oredsson, CEO of Nutri Pharma. ”The granted patent strengthens our position in the European markets and Nutri Pharma’s possibilities for licensing its products with European and global companies. Step by step we are now consolidating our position as world leading within our market segment, which has been confirmed by this patent.”
Nutri Pharma today has agreements with companies such as Del Monte, Scania Diaries, and General Nutrition Company (Numico) and it will make use of this newly granted patent in negotiations with new and potential partners.
New patent strengthens Nutri Pharmas position and protects its soy technology in the European markets
| Source: Solon Eiendom ASA